First patient receives new immunotherapy drug for HIV in clinical trial
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus…
July 12, 2022 - 3 minutes
HIV
Is an HIV Cure Possible? The Future of HIV Therapy
HIV research has come a long way since the virus was discovered in the 1980s.…
February 7, 2022 - 8 minutes
Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
September 13, 2021 - 10 minutes
As J&J Vaccine Fails Phase II, the Quest for an HIV Vaccine Continues
Johnson & Johnson became the latest company to have a failed vaccine trial against HIV…
September 8, 2021 - 5 minutes
HIV Drug Approvals Lift Hopes Amid Missed UN Targets
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers…
February 4, 2021 - 6 minutes
ViiV Healthcare’s Monthly HIV Injection Gains First Approval in Canada
A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for…
March 23, 2020 - 2 minutes
Update: Cancer Immunotherapy Biotech Files for Insolvency
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
December 6, 2019 - 2 minutes
ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV
The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed…
November 22, 2019 - 2 minutes
Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
August 22, 2019 - 2 minutes
HIV Drug Suppresses Virus for Almost Two Years When Other Treatments Fail
A first-in-class HIV treatment developed by the UK company ViiV Healthcare has suppressed the virus…
July 23, 2019 - 2 minutes
EU Approves Two-Drug Pill as First-Line Treatment for HIV
The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as…
July 3, 2019 - 2 minutes
This Biotech Reduces Drug Side Effects Using Silica Gel Implants
DelSiTech is a Finnish company developing injectable silica gel implants that release drugs slowly over…
June 14, 2019 - 3 minutes
